Medication exposure during pregnancy: a pilot pharmacovigilance system using health and demographic surveillance platform.

Details

Ressource 1Download: BIB_F96030311DD9.P001.pdf (302.33 [Ko])
State: Public
Version: author
Serval ID
serval:BIB_F96030311DD9
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Medication exposure during pregnancy: a pilot pharmacovigilance system using health and demographic surveillance platform.
Journal
Bmc Pregnancy and Childbirth
Author(s)
Mosha D., Mazuguni F., Mrema S., Abdulla S., Genton B.
ISSN
1471-2393 (Electronic)
ISSN-L
1471-2393
Publication state
Published
Issued date
2014
Peer-reviewed
Oui
Volume
14
Pages
322
Language
english
Notes
Publication types: Journal Article Publication Status: epublish
Abstract
BACKGROUND: There is limited safety information on most drugs used during pregnancy. This is especially true for medication against tropical diseases because pharmacovigilance systems are not much developed in these settings. The aim of the present study was to demonstrate feasibility of using Health and Demographic Surveillance System (HDSS) as a platform to monitor drug safety in pregnancy.
METHODS: Pregnant women with gestational age below 20 weeks were recruited from Reproductive and Child Health (RCH) clinics or from monthly house visits carried out for the HDSS. A structured questionnaire was used to interview pregnant women. Participants were followed on monthly basis to record any new drug used as well as pregnancy outcome.
RESULTS: 1089 pregnant women were recruited; 994 (91.3%) completed the follow-up until delivery. 98% women reported to have taken at least one medication during pregnancy, mainly those used in antenatal programmes. Other most reported drugs were analgesics (24%), antibiotics (17%), and antimalarial (15%), excluding IPTp. Artemether-lumefantrine (AL) was the most used antimalarial for treating illness by nearly 3/4 compared to other groups of malaria drugs. Overall, antimalarial and antibiotic exposures in pregnancy were not significantly associated with adverse pregnancy outcome. Iron and folic acid supplementation were associated with decreased risk of miscarriage/stillbirth (OR 0.1; 0.08 - 0.3).
CONCLUSION: Almost all women were exposed to medication during pregnancy. Exposure to iron and folic acid had a beneficial effect on pregnancy outcome. HDSS proved to be a useful platform to establish a reliable pharmacovigilance system in resource-limited countries. Widening drug safety information is essential to facilitate evidence based risk-benefit decision for treatment during pregnancy, a major challenge with newly marketed medicines.
Pubmed
Web of science
Open Access
Yes
Create date
18/10/2014 14:24
Last modification date
20/08/2019 16:25
Usage data